UNASSIGNED:比较非增殖性糖尿病视网膜病变(NPDR)患者行联合超声乳化和平坦部玻璃体切除术的术中和术后并发症增殖性糖尿病视网膜病变(PDR)。
未经批准:回顾性,病例系列糖尿病视网膜病变患者在2008年至2017年期间接受了玻璃体切割联合手术。我们比较了术中并发症,包括后囊破裂和视网膜撕裂,术后并发症包括角膜水肿,黄斑水肿(ME),视网膜前膜(ERM),新生血管性青光眼和持续性炎症。
UNASSIGNED:本研究共纳入104例患者的104只眼。24只眼(23.1%)被归类为NPDR,80只眼(76.9%)被归类为PDR。NPDR组最常见的手术指征是ERM(67%)和孔源性视网膜脱离(12.5%),而在PDR组,适应症为玻璃体出血(56%)和牵引性视网膜脱离(19%).术中最常见的并发症是视网膜撕裂(NPDR为8%,PDR为19%,p=0.195),术后并发症为ME(NPDR为29%,PDR为26%,p=0.778)。NPDR组和PDR组之间的术中和术后并发症发生率无统计学差异,即使在调整了混杂因素后;手术时的患者年龄和手术指征。
UASSIGNED:在NPDR和PDR患者行联合晶状体切除术后,在两组中约1/4眼发现新发ME.术中抗VEGF或类固醇给药,无论DR水平如何,超声玻璃体切除术后都应考虑术后强烈的抗炎药和随访。
UNASSIGNED: To compare intra- and postoperative complications in combined phacoemulsification and pars plana vitrectomy surgeries performed in patients with non-proliferative diabetic retinopathy (NPDR) vs. proliferative diabetic retinopathy (PDR).
UNASSIGNED: Retrospective, case series of patients with diabetic retinopathy who underwent combined phacovitrectomy surgery between 2008 and 2017. We compared intraoperative complications including posterior capsular rupture and retinal tear, and postoperative complications including corneal edema, macular edema (ME), epiretinal membrane (ERM), neovascular glaucoma and persistent inflammation.
UNASSIGNED: A total of 104 eyes of 104 patients were included in this study. Twenty-four eyes (23.1%) were categorized as NPDR and 80 eyes (76.9%) as PDR. The most common indications for surgery in the NPDR group were ERM (67%) and rhegmatogenous retinal detachment (12.5%), while in the PDR group, indications were vitreous hemorrhage (56%) and tractional retinal detachment (19%). The most common intraoperative complication was retinal tear (8% in NPDR and 19% in PDR, p = 0.195) and postoperative complication was ME (29% in NPDR and 26% in PDR, p = 0.778). There were no statistically significant differences in intra- and postoperative complication rates between the NPDR and PDR groups, even after adjusting for confounders; patient age at surgery and indication for surgery.
UNASSIGNED: After combined phacovitrectomy in NPDR and PDR patients, new-onset ME was found in about a quarter of eyes in both groups. Intraoperative anti-VEGF or steroid administration, and intense postoperative anti-inflammatory medication and follow-up should be regarded after phacovitrectomy regardless of the DR level.